Clarithromycin targets Kv1.3 in ulcerative colitis, rat study finds
A Frontiers in Immunology study links clarithromycin to Kv1.3 downregulation, Th17/Treg correction, and reduced colitis severity in animal models.
This section contains the website’s posts.